Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis

NCT00150059 ·Status: COMPLETED ·Phase: PHASE4

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

NCT00121381 ·Status: COMPLETED ·Phase: PHASE4

Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life

NCT04900948 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients

NCT00121316 ·Status: COMPLETED ·Phase: PHASE4

Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis

NCT00231998 ·Status: COMPLETED ·Phase: PHASE3

Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

NCT00810862 ·Status: TERMINATED ·Phase: PHASE4

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

NCT00925730 ·Status: COMPLETED ·Phase: PHASE4

A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis

NCT00484003 ·Status: COMPLETED ·Phase: PHASE4

Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

NCT00117377 ·Status: COMPLETED ·Phase: PHASE4

Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

NCT00480896 ·Status: COMPLETED ·Phase: PHASE3

Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis

NCT00367393 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis

NCT00691262 ·Status: COMPLETED ·Phase: PHASE3

Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis

NCT00560326 ·Status: COMPLETED ·Phase: PHASE2

Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis

NCT00379678 ·Status: COMPLETED

Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis

NCT00232115 ·Status: COMPLETED ·Phase: PHASE3

Combination Therapy for Atopic Dermatitis

NCT00119158 ·Status: COMPLETED ·Phase: PHASE4

Pimecrolimus and Epidermal Barrier Function

NCT01132079 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification

NCT00124709 ·Status: TERMINATED ·Phase: PHASE4

Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis

NCT00148746 ·Status: COMPLETED ·Phase: NA

Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis

NCT00232011 ·Status: COMPLETED ·Phase: PHASE3

Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis

NCT03559075 ·Status: COMPLETED

Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis

NCT00535691 ·Status: COMPLETED ·Phase: PHASE2

Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

NCT01745159 ·Status: COMPLETED ·Phase: PHASE4

Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

NCT00523952 ·Status: COMPLETED ·Phase: PHASE3

Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment

NCT00480610 ·Status: COMPLETED ·Phase: PHASE3